Related Experiment Videos
Acute Nonvariceal Upper Gastrointestinal Hemorrhage
1Division of Gastroenterology, University of Michigan, 3912 Taubman Center, Box 0362, Ann Arbor, MI 48109-0362, USA. gelta@umich.edu
Current Treatment Options in Gastroenterology
|March 7, 2002
Summary
Upper endoscopy helps manage nonvariceal upper gastrointestinal bleeding by identifying rebleeding risks. This allows outpatient care for some patients, reducing costs and hospital stays.
Area of Science:
- Gastroenterology
- Endoscopy
- Internal Medicine
Background:
- Nonvariceal upper gastrointestinal bleeding (NVUGIB) management has evolved.
- Hospitalization for NVUGIB has decreased, with most patients undergoing endoscopy within 24 hours.
Purpose of the Study:
- To assess the role of upper endoscopy in triaging NVUGIB patients.
- To evaluate endoscopic hemostatic therapy and acid suppression for preventing rebleeding.
Main Methods:
- Review of endoscopic practices for NVUGIB.
- Analysis of endoscopic hemostatic techniques (thermal and nonthermal therapies).
- Evaluation of high-dose omeprazole in high-risk patients and post-endoscopic treatment.
Main Results:
- Endoscopic hemostatic therapy is used in 20-35% of NVUGIB cases.
- Endoscopic retreatment is superior to surgery for recurrent ulcer bleeding.
- High-dose omeprazole significantly reduces rebleeding and surgical intervention rates.
Conclusions:
- Upper endoscopy is crucial for triaging NVUGIB patients, enabling outpatient care and cost savings.
- Endoscopic therapy and potent acid suppression are effective in managing NVUGIB and preventing rebleeding.